These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6154362)

  • 1. The relationship of alloreactivity to syngeneic tumor immunity.
    Greene MI; Perry LL
    Transplant Proc; 1980 Mar; 12(1):80-6. PubMed ID: 6154362
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell antigen recognition.
    Perry LL; Greene MI
    J Immunol; 1980 Aug; 125(2):738-48. PubMed ID: 6967088
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    Parmiani G; Ballinari D; Sensi ML
    J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL.
    Kaneko Y; Natsuume-Sakai S; Migita S
    J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed hypersensitivity to crude and partially purified murine tumor-specific transplantation antigens and alloantigens utilizing the footpad swelling assay.
    Macek CM; Kahan BD; Pellis NR
    J Immunol; 1980 Oct; 125(4):1639-43. PubMed ID: 6157743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps.
    Fan J; Ahmed A; Bonavida B
    J Immunol; 1980 Dec; 125(6):2444-53. PubMed ID: 6159409
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limiting dilution analysis of alloantigen-reactive T lymphocytes. V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens.
    Cerottini JC; MacDonald HR
    J Immunol; 1981 Feb; 126(2):490-6. PubMed ID: 6450245
    [No Abstract]   [Full Text] [Related]  

  • 9. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
    Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
    J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen receptors on murine T lymphocytes in contact sensitivity. II. Presentation and characterization of syngeneic anti-idiotype serum against DNFB-sensitized T cells.
    Moorhead JW; Sy MS
    J Immunol; 1982 Jun; 128(6):2533-8. PubMed ID: 6176644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delayed hypersensitivity reaction in mice immunized with Bacillus megaterium H].
    Zatula DG; Zaval'niuk AK; Lisovenko GS
    Mikrobiol Zh (1978); 1981; 43(2):235-40. PubMed ID: 6164906
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of a fetal calf serum-induced T cell line. I. H-2 restricted growth and expression of membrane-bound and released molecules bearing 5936-idiotypic determinants.
    Suzan M; Bourgois A; Boned A; De Preval C; Golstein P; Rubin B
    J Immunol; 1981 Sep; 127(3):992-9. PubMed ID: 6167637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell hybrids as a source of antigen-specific factors.
    Taussig MJ; Holliman A; Corvalán JR
    Transplant Proc; 1980 Sep; 12(3):427-31. PubMed ID: 6164137
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells.
    Sia DY; Lachmann PJ; Leung KN
    Immunology; 1984 Apr; 51(4):755-63. PubMed ID: 6200428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple composition of foreign alloantigens on a murine fibrosarcoma [proceedings].
    Invernizzi G; Carbone G; Parmiana G
    Folia Biol (Praha); 1976; 22(6):393-4. PubMed ID: 1001559
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed hypersensitivity reactions to virus-augmented syngeneic and allogeneic tumor associated antigens.
    Takeichi N; Oikawa T; Austin FC; Boone CW
    Hokkaido Igaku Zasshi; 1988 May; 63(3):343-7. PubMed ID: 2839400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressed induction and expression of delayed hypersensitivity responses in BALB/c mice infected with Trypanosoma venezuelense.
    Pérez HA; Bolívar J; Araque W; De la Rosa M
    Acta Cient Venez; 1987; 38(1):73-6. PubMed ID: 3501216
    [No Abstract]   [Full Text] [Related]  

  • 19. T cell lines active in the delayed-type hypersensitivity reaction (DTH).
    Weiss S; Dennert G
    J Immunol; 1981 May; 126(5):2031-5. PubMed ID: 6971319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.